Pifzer

Pifzer's vulnerability footprint is concentrated in medical infusion-delivery systems, including the Plum A+ and SymbiQ product lines, where recurring exposure centers on sensitive-data handling and authorization controls. The durable weakness signal reflects challenges endemic to connected medical devices: cleartext storage of sensitive information, exposure of credentials and authentication data to unauthorized actors, improper authorization logic, and insufficient verification of data authenticity—issues that carry particular weight in clinical environments where device integrity directly affects patient safety. Current severity, exploitation activity, and exposure counts are shown alongside this summary.